|
WO2005026375A2
(en)
|
2003-05-22 |
2005-03-24 |
Fraunhofer Usa, Inc. |
Recombinant carrier molecule for expression, delivery and purification of target polypeptides
|
|
JP2009502207A
(ja)
|
2005-08-03 |
2009-01-29 |
フラウンホーファー ユーエスエー， インコーポレイテッド |
イムノグロブリンの産生のための組成物および方法
|
|
WO2008110937A2
(en)
*
|
2007-03-13 |
2008-09-18 |
Humabs Llc |
Antibodies against h5n1 strains of influenza a virus
|
|
WO2009009759A2
(en)
|
2007-07-11 |
2009-01-15 |
Fraunhofer Usa, Inc. |
Yersinia pestis antigens, vaccine compositions, and related methods
|
|
CA2731686C
(en)
|
2008-07-25 |
2020-04-07 |
Institute For Research In Biomedicine |
Neutralizing anti-influenza a virus antibodies and uses thereof
|
|
US8871207B2
(en)
|
2008-07-25 |
2014-10-28 |
Humabs, LLC |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
|
US8734803B2
(en)
|
2008-09-28 |
2014-05-27 |
Ibio Inc. |
Humanized neuraminidase antibody and methods of use thereof
|
|
GB0818356D0
(en)
*
|
2008-10-07 |
2008-11-12 |
Istituto Superiore Di Sanito |
Antibodies
|
|
PL2350128T3
(pl)
|
2008-10-22 |
2015-03-31 |
Inst Res Biomedicine |
Sposoby wytwarzania przeciwciał z komórek plazmatycznych
|
|
CA2761648C
(en)
*
|
2009-05-11 |
2019-03-12 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
|
|
US8784819B2
(en)
*
|
2009-09-29 |
2014-07-22 |
Ibio Inc. |
Influenza hemagglutinin antibodies, compositions and related methods
|
|
CA2807664A1
(en)
*
|
2010-08-12 |
2012-02-16 |
Theraclone Sciences, Inc. |
Anti-hemagglutinin antibody compositions and methods of use thereof
|
|
CN102775469B
(zh)
*
|
2011-05-12 |
2018-02-09 |
厦门大学 |
甲型流感病毒核衣壳蛋白的抗原表位及其用途
|
|
AU2011373387B2
(en)
|
2011-07-18 |
2017-06-29 |
Institute For Research In Biomedicine |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
|
JP2013087069A
(ja)
*
|
2011-10-17 |
2013-05-13 |
Toyobo Co Ltd |
Ｈ５亜型インフルエンザウイルスを特異的に認識するモノクローナル抗体
|
|
MX367743B
(es)
|
2011-12-05 |
2019-09-04 |
Trellis Bioscience Llc |
Anticuerpos utiles para la inmunizacion pasiva de influenza.
|
|
WO2013105896A1
(en)
*
|
2012-01-12 |
2013-07-18 |
Temasek Life Sciences Laboratory Limited |
Monoclonal antibodies targeting neutralizing epitopes on h5 influenza virus of clade 2.3
|
|
US9969794B2
(en)
|
2012-05-10 |
2018-05-15 |
Visterra, Inc. |
HA binding agents
|
|
CN104968367B
(zh)
|
2012-11-13 |
2018-04-13 |
弗·哈夫曼-拉罗切有限公司 |
抗血凝素抗体和使用方法
|
|
MX387277B
(es)
*
|
2013-03-14 |
2025-03-12 |
Contrafect Corp |
Composiciones basadas en anticuerpos neutralizantes suministrados intranasalmente para eficacia terapéutica aumentada.
|
|
SI3052192T1
(sl)
|
2013-10-02 |
2020-11-30 |
Medimmune, Llc |
Nevtralizarijoča protitelesa proti-influenci A in njihove uporabe
|
|
US10639370B2
(en)
|
2014-02-04 |
2020-05-05 |
Contrafect Corporation |
Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
|
|
JP6712428B2
(ja)
|
2014-02-04 |
2020-06-24 |
コントラフェクト コーポレイション |
インフルエンザ受動免疫に有用な抗体ならびにその使用のための組成物、組合せおよび方法
|
|
JP6614523B2
(ja)
*
|
2014-03-28 |
2019-12-04 |
地方独立行政法人神奈川県立産業技術総合研究所 |
インフルエンザウイルスのｒｎａ依存性ｒｎａポリメラーゼのｐｂ２サブユニットに対するモノクローナル抗体
|
|
KR101628331B1
(ko)
*
|
2014-03-28 |
2016-06-08 |
주식회사 녹십자엠에스 |
인플루엔자 a 바이러스 특이적 단클론 항체 및 이를 이용한 인플루엔자 감염 치료 및 진단 방법
|
|
MX392761B
(es)
|
2014-07-15 |
2025-03-21 |
Medimmune Llc |
Anticuerpos anti-influenza b neutralizantes y usos de los mismos.
|
|
TWI702229B
(zh)
|
2014-12-19 |
2020-08-21 |
美商再生元醫藥公司 |
流行性感冒病毒血球凝集素之人類抗體
|
|
EA201792500A1
(ru)
|
2015-05-13 |
2018-04-30 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Aav-опосредованная экспрессия антител против гриппа и способы их использования
|
|
HUE056407T2
(hu)
|
2015-06-01 |
2022-02-28 |
Medimmune Llc |
Neutralizáló influenzaellenes kötõmolekulák és alkalmazásaik
|
|
EP3374390A1
(en)
|
2015-11-13 |
2018-09-19 |
Visterra, Inc. |
Compositions and methods for treating and preventing influenza
|
|
SG11201805001UA
(en)
|
2016-01-13 |
2018-07-30 |
Medimmune Llc |
Method of treating influenza a
|
|
AU2017222564A1
(en)
|
2016-02-24 |
2018-09-06 |
Visterra, Inc. |
Formulations of antibody molecules to influenza virus
|
|
PL238020B1
(pl)
|
2016-09-12 |
2021-06-28 |
Inst Biotechnologii I Antybiotykow |
Kompozycja przeciwciał monoklonalnych przeciwko hemaglutyninie wirusów grypy serotypu H5 i jej zastosowanie, hybrydomy produkujące rzeczone przeciwciała, sposób diagnozowania infekcji wirusami grypy serotypu H5 oraz zestawy diagnostyczne
|
|
JOP20190200A1
(ar)
|
2017-02-28 |
2019-08-27 |
Univ Pennsylvania |
تركيبات نافعة في معالجة ضمور العضل النخاعي
|
|
PT3589730T
(pt)
|
2017-02-28 |
2024-02-28 |
Univ Pennsylvania |
Vetor de vírus adenoassociado (aav) de clado f e suas utilizações
|
|
UY37620A
(es)
|
2017-02-28 |
2018-08-31 |
Univ Pennsylvania |
Vacunas contra la gripe mediadas por aav novedosas
|
|
MY201312A
(en)
|
2017-06-02 |
2024-02-16 |
Pfizer |
Antibodies specific for flt3 and their uses
|
|
US11230593B2
(en)
|
2019-03-25 |
2022-01-25 |
Visterra, Inc. |
Compositions and methods for treating and preventing influenza
|
|
EP4087590A4
(en)
*
|
2020-01-12 |
2024-05-15 |
Vanderbilt University |
HUMAN ANTIBODIES AGAINST CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS
|
|
WO2021202815A1
(en)
*
|
2020-03-31 |
2021-10-07 |
Northeastern University |
Colorimetric and multiplexed isothermal rna-and antibody-based assay for sars-cov-2 and other viral diagnostics and cell analysis
|
|
CN114181302B
(zh)
*
|
2020-09-14 |
2023-03-24 |
东莞市朋志生物科技有限公司 |
针对甲型流感病毒的抗体、试剂盒和载体
|
|
US12319747B2
(en)
*
|
2023-07-03 |
2025-06-03 |
Medicovestor, Inc. |
Methods of using anti-SP17 immunotherapeutics
|
|
US12364777B2
(en)
|
2023-10-20 |
2025-07-22 |
Medicovestor, Inc. |
Homodimeric antibodies for use in treating cancers and methods of use
|
|
US12116410B1
(en)
|
2023-12-26 |
2024-10-15 |
Medicovestor, Inc. |
Methods of manufacturing dimeric antibodies
|
|
US12600795B2
(en)
|
2023-12-26 |
2026-04-14 |
Medicovestor, Inc. |
Oligomeric IgG for immunotherapeutics and diagnostics
|
|
WO2025245380A1
(en)
*
|
2024-05-22 |
2025-11-27 |
Vanderbilt University |
Antibody generation
|